Eyelid drooping after repeated eye injections
Part of Eyes & vision clinical trials.
This study checks if repeated anti-VEGF eye injections, used to treat retinal diseases, can cause the upper eyelid to droop. It follows people getting their first injection in one eye and watches for eyelid changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to get anti-VEGF injections in one eye only for a retinal condition.
- You have never had an eye injection before.
- You can attend all study visits and follow instructions.
- Your eyelids can be measured reliably in both eyes.
- You do not have a history of eyelid drooping, eyelid surgery, certain nerve or muscle disorders, or recent eye/orbital problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how eye pressure changes right after an eye injection. It aims to help doctors better understand and manage pressure spikes after treatment.
This study tests a new treatment for Chinese patients whose droopy upper eyelid (acquired blepharoptosis) seriously affects their vision. It may help if your eyelid droops low enough to block part of your sight and you haven't had previous corrective surgery or certain eye conditions.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
This study looks at how the eyes of people with diabetes-related swelling in the retina change after their very first anti-VEGF injection. By measuring early changes in OCT scans, doctors hope to learn more about how well the treatment works and how to predict outcomes.
This trial tests a new eye-numbing gel against the standard numbing method to see which works better for patients getting regular anti-VEGF injections in the eye.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.